TY  - GEN
AU  - Aapro,Matti
AU  - Ruiz-Borrego,Manuel
AU  - Hegg,Roberto
AU  - Kukielka-Budny,Bozena
AU  - Morales,Serafin
AU  - Cinieri,Saverio
AU  - Freitas-Junior,Ruffo
AU  - Garcia-Estevez,Laura
AU  - Szombara,Ewa
AU  - Borges,Giuliano Santos
AU  - Passalacqua,Rodolfo
AU  - Hervieu,Helene
AU  - Groc,Mélanie
AU  - Villanova,Gustavo
TI  - Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial)
SN  - 1532-3080
PY  - 2019///1203
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Paclitaxel
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Treatment Outcome
KW  - Vinorelbine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.breast.2019.01.009
ER  -